New hope for kids with serious kidney inflammation
NCT ID NCT07354503
Summary
This study aims to see if a drug called telitacicept is a safe and effective treatment for kidney inflammation in children with IgA vasculitis, a condition that can lead to long-term kidney damage. It will compare telitacicept to standard steroid treatments in about 300 children aged 3-17. The goal is to find a treatment that better controls the disease and reduces harmful protein in the urine, potentially with fewer side effects than current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA VASCULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.